Characteristics of Circulating KSHV-Infected Cells during Active KSHV plus Multicentric Castleman Disease

被引：1

作者：

De Fremont, Gregoire Martin ^{[1
,2
]}

Vanjak, Anthony ^{[1
,2
]}

Sbihi, Zineb ^{[1
,2
]}

Knapp, Silene ^{[1
,2
]}

Garzaro, Margaux ^{[1
,2
]}

Chbihi, Marwa ^{[1
,2
]}

Fournier, Benjamin ^{[3
,4
,5
]}

Poirot, Justine ^{[2
,6
]}

Dossier, Antoine ^{[1
,2
]}

Villemonteix, Juliette ^{[1
,2
]}

Meignin, Veronique ^{[7
]}

Galicier, Lionel ^{[8
]}

Bertinchamp, Remi ^{[9
]}

Le Goff, Jerome ^{[10
]}

Salmona, Maud ^{[11
]}

Flamarion, Edouard ^{[12
]}

Cassius, Charles ^{[13
]}

Lebbe, Celeste ^{[14
]}

Ronchetti, Anne Marie ^{[15
]}

Latour, Sylvain ^{[16
]}

Carcelain, Guislaine ^{[1
,2
]}

Oksenhendler, Eric ^{[9
,17
]}

Boutboul, David ^{[1
,2
,18
]}

机构：

[1] Univ Paris Cite, Inst Rech St Louis, Equipe Insight, INSERM U976,HIPI, Paris, France

[2] Hop St Louis, Paris, France

[3] INSERM, Imagine Inst, UMR 1163, Lab Lymphocyte Activat & Susceptibil EBV Infect, Paris, France

[4] Univ Paris Cite Paris, Paris, France

[5] Inst Imagine, Paris, France

[6] Univ Paris Cite, Inst Rech St Louis, INSERM U976, HIPI, Paris, France

[7] Hop St Louis, AP HP, Anat Pathol, Paris, France

[8] St Louis Univ Hosp, AP HP, Dept Clin Immunol, Paris, France

[9] Hop St Louis, Clin Immunol Dept, Paris, France

[10] Univ Paris, St Louis Hosp, APHP Nord, Microbiol, Paris, France

[11] Hop St Louis, Virol Dept, Paris, France

[12] Hop Europeen Georges Pompidou, Internal Med Dept, Paris, France

[13] St Louis Hosp, Dermatol Dept, Paris, France

[14] Hop St Louis, Dermatol Dept, Paris, France

[15] Ctr Hosp Sud Francilien, Hematol Dept, Corbeil Essonnes, France

[16] Hop Necker Enfants Malad, Inst IMAGINE, Paris, France

[17] Hop St Louis, AP HP, Natl Reference Ctr Castleman Dis, Paris, France

[18] Hop St Louis, Natl Reference Ctr Castleman Dis, Paris, France

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-165486

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3577 / 3578

页数：2

共 50 条

[31] KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies
Carbone, Antonino
De Paoli, Paolo
Gloghini, Annunziata
Vaccher, Emanuela
INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (02) : 251 - 261
[32] KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease
Mark N Polizzotto
Thomas S Uldrick
Victoria Wang
Karen Aleman
Kathleen M Wyvill
Vickie Marshall
Stefania Pittaluga
Dierdre O'Mahony
Denise Whitby
Giovanna Tosato
Seth M Steinberg
Richard F Little
Robert Yarchoan
Infectious Agents and Cancer, 5 (Suppl 1)
[33] The potential impacts of early secreted antigenic target of 6 kDa ofMycobacterium tuberculosison KSHV-infected cells
Dai, Lu
Jung, Bock-Gie
Chen, Jungang
Samten, Buka
Forrest, James Craig
Post, Steven R.
Qin, Zhiqiang
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 4028 - 4032
[34] Extracellular Vesicles From KSHV-Infected Cells Stimulate Antiviral Immune Response Through Mitochondrial DNA
Jeon, Hyungtaek
Lee, Jisu
Lee, Suhyuk
Kang, Su-Kyung
Park, Sang June
Yoo, Seung-Min
Lee, Myung-Shin
FRONTIERS IN IMMUNOLOGY, 2019, 10
[35] Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells
Nayar, Utthara
Akar, Gunkut
Shoemaker, Robert H.
Sei, Shizuko
Cesarman, Ethel
BLOOD, 2012, 120 (21)
[36] Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease
Ramaswami, Ramya
Lurain, Kathryn
Widell, Anaida
Polizzotto, Mark N.
Goncalves, Priscila H.
Lindsley, Matthew
Steinberg, Seth M.
Whitby, Denise
Uldrick, Thomas S.
Yarchoan, Robert
BLOOD, 2018, 132
[37] Leukemic phase of a large B-cell lymphoma arising in KSHV-associated multicentric Castleman disease
Debord, Camille
Eveillard, Marion
BLOOD, 2015, 126 (16) : 1966 - 1966
[38] Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
Vickie Marshall
Alex Ray
Soo-Jin Han
Thomas Uldrick
Eugene Barsov
Octavio Quinones
Robert Leighty
Nazzarena Labo
Kathy Wyvill
Karen Aleman
Mark N Polizzotto
Richard F Little
David Ott
Robert Yarchoan
Rolf Renne
Denise Whitby
Infectious Agents and Cancer, 7 (Suppl 1)
[39] KSHV/HHV-8-associated multicentric Castleman disease and nodal Kaposi sarcoma displaying a lymphangiectatic pattern
Ocampo-Gonzalez, Fernando Alekos
Bhagat, Govind
BLOOD, 2024, 144 (05) : 587 - 587
[40] Can KSHV viral load be used to differentiate multicentric Castleman's disease from Kaposi's sarcoma?
Fish, R.
Paul, J.
Hargreves, S.
Edwards, S.
Nourasdeghi, M.
Miller, R.
HIV MEDICINE, 2010, 11 : 12 - 13

← 1 2 3 4 5 →